Form 4 for PRVA Privia Health Group, Inc.
Accepted 2022-08-29 00:00:00 ET · period of report 2022-08-25 · accession 0001759655-22-000122 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-29 | 2022-08-25+ | PRVA | Morris Matthew Shawn | CEO, Dir | S - Sale+OE | $40.99 | -134.9K | 127.0K | -52% | -$5.53M |
| DM | 2022-08-29 | 2022-08-25+ | PRVA | Morris Matthew Shawn | CEO, Dir | M - OptEx | $2.00 | +134.9K | 189.8K | +246% | +$269.8K |
| DM | 2022-08-29 | 2022-08-25+ | PRVA | Morris Matthew Shawn | CEO, Dir | M - OptEx | $0.00 | -134.9K | 4.73M | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value per share | 2022-08-25 | S | D | 20,618 | $42.72 | 122,339 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.41 to $43.19 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 2 | Common | Common Stock, $0.01 par value per share | 2022-08-25 | S | D | 600 | $43.53 | 121,739 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.43 to $43.59 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 3 | Common | Common Stock, $0.01 par value per share | 2022-08-26 | M | A | 66,809 | $2.00 | 188,548 | D | — | — | |
| 4 | Common | Common Stock, $0.01 par value per share | 2022-08-26 | S | D | 43,935 | $39.36 | 144,613 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.86 to $39.85 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock, $0.01 par value per share | 2022-08-26 | S | D | 700 | $42.03 | 121,739 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.91 to $42.20 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 6 | Common | Common Stock, $0.01 par value per share | 2022-08-25 | M | A | 68,102 | $2.00 | 189,841 | D | — | — | |
| 7 | Common | Common Stock, $0.01 par value per share | 2022-08-25 | S | D | 46,884 | $41.95 | 142,957 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.41 to $42.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 8 | Common | Common Stock, $0.01 par value per share | 2022-08-26 | S | D | 4,574 | $41.26 | 122,439 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.90 to $41.83 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 9 | Common | Common Stock, $0.01 par value per share | 2022-08-26 | S | D | 17,600 | $40.28 | 127,013 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.86 to $40.84 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 10 | Derivative | Stock Option (Right to Purchase) | 2022-08-25 | M | D | 68,102 | $0.00 | 4,796,096 | D | $2.00 · — to 2033-08-27 | 68,102 Common Stock | (F9) Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,974,108 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022 |
| 11 | Derivative | Stock Option (Right to Purchase) | 2022-08-26 | M | D | 66,809 | $0.00 | 4,729,287 | D | $2.00 · — to 2033-08-27 | 66,809 Common Stock | (F9) Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,974,108 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022 |